Developer docs
API playgroundTry for free, no card

Search company profiles

Conception X

Full company profile

uuid000lziy

Namestring
Conception X
Legal namestring
Conception X Limited
Websiteurl
conceptionx.org
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Conception X is a not-for-profit venture-building platform founded in 2018 and headquartered in London that commercialises deep tech research by turning European PhD researchers into founders. It operates two core programmes: Venture Scientist 100 (VS100), a selective 9-month part-time fellowship admitting approximately 100 PhD founders per cohort and delivering 18 expert-led co-building sessions covering customer discovery, business model design, IP strategy, hardware prototyping, team building and fundraising; and Raise, a 10-week investment readiness track for science teams preparing to raise pre-seed or seed capital. Both programmes are provided at no cost to participants and the organisation explicitly takes no equity in the companies it helps create.

The platform is anchored on a curated ecosystem of 1,500+ science founders, investors, mentors and industry decision-makers, supported by formal partnerships with leading European universities (UCL, Oxford, Cambridge, Manchester, Imperial, plus 15+ Irish institutions) and an Industry Advisory Board that includes NVIDIA, AstraZeneca, GSK, Unilever, EDF Energy, XTX Markets, Barclays, Coca-Cola Europacific Partners, Schott and IBM. Capital deployment for portfolio companies is facilitated through the Conception X Angel Syndicate and a strategic partnership with XTX Ventures, offering up to £300k in equity investment for top-performing teams at Demo Days attended by 200+ deeptech investors. Legal infrastructure is provided by Orrick. Since inception the organisation reports 700+ founders launched, 205 startups created, a combined portfolio valuation exceeding £1B, and three exits: Rahko (acquired by Odyssey Therapeutics in 2022), Kapacity (acquired by EnergyHub in 2024) and Humanloop (team acquired by Anthropic in 2025).

The business model is non-revenue-generating: programmes are free, no equity is taken, and the source material does not disclose programme funding sources beyond implied corporate partnerships. The go-to-market is community-led (university scouting, peer community) and event-driven (annual Demo Days, Slush and industry conference presence). With a lean 1-10 person team, Conception X functions as a capital-light platform intermediary whose economic value is captured indirectly through portfolio company outcomes rather than through direct monetisation of its services.

Short descriptiontext

Conception X is a London-based not-for-profit venture builder founded in 2018 that runs the Venture Scientist 100 fellowship and Raise investment-readiness programme to help European PhD researchers commercialise deep tech research into startups without taking equity.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture building programme, deep tech accelerator, PhD fellowship, science commercialisation, startup investor readiness
Industry3 codes
PRIMARYFSANAAAH
Venture Studios / Company Builders
SECONDARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Venture Builder / Startup Accelerator
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Non-revenue generating (Not-for-profit)
TypeSubscription Recurring
Description

Conception X is explicitly stated as a not-for-profit organisation. The flagship VS100 programme is free for researchers and no equity is taken in the companies created. Raise is also free. Investment opportunities through the Angel Syndicate and XTX Ventures are separate from programme participation.

conceptionx.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Others, Technology or R&D, Infrastructure
Pricing details1 tier
1Venture Scientist 100 - Free merit-based fellowship
ModelFreemiumBilling cadenceAnnual
Notes

No fees, no equity taken. Free access to 18 co-building sessions, coaching for top performers, legal support via partner Orrick, and access to investor network. Investment opportunity of up to £300k available for selected top teams.

conceptionx.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Conception X runs a 9-month part-time venture-building fellowship (Venture Scientist 100) for approximately 100 PhD researchers annually and a 10-week investment readiness programme (Raise) for incorporated science teams. The organisation provides structured co-building sessions, 1:1 coaching, legal support via Orrick, investor introductions to a network of 700+ investors, and Demo Day pitching opportunities, all free of charge with no equity taken.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Conception X is a not-for-profit venture-building platform that operates two core programmes for PhD researchers: Venture Scientist 100 (a 9-month fellowship) and Raise (a 10-week investment readiness track). The platform provides access to a curated ecosystem network of 1,500+ science founders, investors, and industry experts, an Industry Advisory Board featuring partners like NVIDIA, AstraZeneca, and IBM, and investment pathways through the Conception X Angel Syndicate and XTX Ventures partnership offering up to £300k. The company has helped launch 205 startups valued at over £1 billion, with 3 exits including acquisitions by EnergyHub and Odyssey Therapeutics, and team acquisitions by Anthropic.

Product and service2 records
1Venture Scientist 100
CategoryCore Programme
Description

Selective 9-month part-time venture-building fellowship for approximately 100 PhD founders annually, designed to run alongside PhD research. Includes 18 active co-building sessions, investment and expert coaching for top teams, 1:1 coaching, access to Europe's largest peer community of science founders, and integration with the PhD timeline. Free of charge with no equity taken.

2Raise
CategoryCore Programme
Description

10-week investment readiness programme for incorporated science teams preparing to raise pre-seed or seed funding. Includes personalized coaching, narrative and pitch development, fundraising strategy, direct access to a 700+ investor network, optional co-building sessions, legal support through partner Orrick, and the opportunity to pitch for up to £300k in equity investment from the Conception X Angel Syndicate and XTX Ventures at Demo Day.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Top-tier legal expertise partner providing support to programme participants on term sheets, fundraise structure, and IP guidance. Orrick has a proven track record advising innovative companies across Silicon Valley and Europe's tech ecosystem.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key academic partner with Professor David Barber serving on the Academic Advisory Board. Multiple founders from UCL have gone through the programme including Rahko (CX18) and TurinTech (CX19).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key academic partner with Professor Ramana Nanda (Entrepreneurial Finance) on Academic Advisory Board. Notable alumni include Infinitopes (CX20, £27M raised) and GambitBio (CX23).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner with Pam Garside (Partner at NewHealth & Fellow of Judge Business School) on Academic Advisory Board. Alumni include Nanomation (CX22) and ReactWise (CX24).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner with Professors Aline Miller and Chris Taylor on Academic Advisory Board. Alumni include ARDHANN (CX25) and NeuWave (CX23).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner with Professor Ramana Nanda on Academic Advisory Board. Alumni include Radiant Science (CX22/CX24).

Strategic tierMinorTypeGTM or Marketing Partner
Description

Industry Advisory Board member providing access to industry decision-makers and potential investment or partnership opportunities for portfolio companies.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Industry Advisory Board member with multiple representatives (Dr. Graham Clarke, Ryan Bate). Provides access to pharma/biotech expertise and potential commercial partnerships.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Industry Advisory Board member (Dr. Uche Agwo, Director of Academic Liaison) providing biotech/pharma industry perspective and potential partnerships.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global venture builder/accelerator running cohort-based programmes to help early-stage founders build companies. While broader than deep tech, Antler competes for technical talent and operates similar fellowship-style programmes with investor demo days.

TypeRegional player
Description

UK university business incubator partnership supporting deep tech and science founders from member universities. Provides similar incubation infrastructure, mentoring, and investor access for academic spinouts.

TypeDirect peer
Description

UK-based venture builder creating science-led startups across similar deeptech domains. Closest comparable to Conception X, also focuses on training scientists to become founders and operates cohort-based programmes with university and corporate partnerships.

TypeRegional player
Description

UK-focused deep tech accelerator and venture builder with programmes supporting science founders. Comparable mission of supporting deeptech ventures from universities with similar fellowship-style programming.

TypeOthers
Description

UK-based venture firm with significant deep tech investment activity and ecosystem programmes supporting science founders. While primarily an investor rather than builder, operates similar ecosystem-building activities and participates in Conception X-style demo days.

TypeBroad incumbent
Description

Established global accelerator network with multiple deep tech-focused programmes. Provides cohort-based mentoring, investor access, and demo days similar to Conception X's model, though operates as a for-profit entity taking equity.

TypeDirect peer
Description

Global venture builder specifically targeting technical talent (often PhDs and researchers) to form companies from scratch. Operates similar cohort-based programmes with a focus on first-time technical founders, comparable to Conception X's VS100 model.

TypeBroad incumbent
Description

Multi-stage venture fund operating multiple vertical-specific accelerator programmes (HAX for hardware, IndieBio for biotech) similar to Conception X's deep tech specialization. Competes for science founder talent and provides comparable demo day investor access.

9Y Combinator
TypeBroad incumbent
Description

Premier global accelerator with significant deep tech portfolio including AI and biotech companies. Operates a more capital-intensive model with equity participation, but competes for early-stage technical founder mindshare and provides comparable investor demo day access.

TypeDirect peer
Description

Global deep tech accelerator providing objectives-based mentoring for science and technology founders. Operates similar cohort structures and supports ventures from lab to market, with strong university and industry partnerships comparable to Conception X.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability12 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Conception X

Venture Builder / Startup Acceleratorconceptionx.org

Conception X is a London-based not-for-profit venture builder founded in 2018 that runs the Venture Scientist 100 fellowship and Raise investment-readiness programme to help European PhD researchers commercialise deep tech research into startups without taking equity.

What Conception X does

Conception X is a not-for-profit venture-building platform founded in 2018 and headquartered in London that commercialises deep tech research by turning European PhD researchers into founders. It operates two core programmes: Venture Scientist 100 (VS100), a selective 9-month part-time fellowship admitting approximately 100 PhD founders per cohort and delivering 18 expert-led co-building sessions covering customer discovery, business model design, IP strategy, hardware prototyping, team building and fundraising; and Raise, a 10-week investment readiness track for science teams preparing to raise pre-seed or seed capital. Both programmes are provided at no cost to participants and the organisation explicitly takes no equity in the companies it helps create.

The platform is anchored on a curated ecosystem of 1,500+ science founders, investors, mentors and industry decision-makers, supported by formal partnerships with leading European universities (UCL, Oxford, Cambridge, Manchester, Imperial, plus 15+ Irish institutions) and an Industry Advisory Board that includes NVIDIA, AstraZeneca, GSK, Unilever, EDF Energy, XTX Markets, Barclays, Coca-Cola Europacific Partners, Schott and IBM. Capital deployment for portfolio companies is facilitated through the Conception X Angel Syndicate and a strategic partnership with XTX Ventures, offering up to £300k in equity investment for top-performing teams at Demo Days attended by 200+ deeptech investors. Legal infrastructure is provided by Orrick. Since inception the organisation reports 700+ founders launched, 205 startups created, a combined portfolio valuation exceeding £1B, and three exits: Rahko (acquired by Odyssey Therapeutics in 2022), Kapacity (acquired by EnergyHub in 2024) and Humanloop (team acquired by Anthropic in 2025).

The business model is non-revenue-generating: programmes are free, no equity is taken, and the source material does not disclose programme funding sources beyond implied corporate partnerships. The go-to-market is community-led (university scouting, peer community) and event-driven (annual Demo Days, Slush and industry conference presence). With a lean 1-10 person team, Conception X functions as a capital-light platform intermediary whose economic value is captured indirectly through portfolio company outcomes rather than through direct monetisation of its services.

Conception X firmographics

Firmographics
Name
Conception X
Legal name
Conception X Limited
Website
https://conceptionx.org
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Conception X is a London-based not-for-profit venture builder founded in 2018 that runs the Venture Scientist 100 fellowship and Raise investment-readiness programme to help European PhD researchers commercialise deep tech research into startups without taking equity.
Ownership category
akta.pro rank

Conception X industry classification

Industry
Product category
Venture Builder / Startup Accelerator
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYFSANAAAH
Venture Studios / Company Builders
SECONDARYFSANAAAM
Accelerators & Incubators (Investor-Operated)
SECONDARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)

Keywords

  • Venture building programme
  • Deep tech accelerator
  • PhD fellowship
  • Science commercialisation
  • Startup investor readiness

Where Conception X is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Conception X business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others, Technology or R&D, Infrastructure

Revenue model

  1. Non-revenue generating (Not-for-profit): Conception X is explicitly stated as a not-for-profit organisation. The flagship VS100 programme is free for researchers and no equity is taken in the companies created. Raise is also free. Investment opportunities through the Angel Syndicate and XTX Ventures are separate from programme participation.

Pricing tiers

ModelBillingPrice
FreemiumAnnualVenture Scientist 100 - Free merit-based fellowship

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Conception X product offering

Product offering

Core offering

Conception X runs a 9-month part-time venture-building fellowship (Venture Scientist 100) for approximately 100 PhD researchers annually and a 10-week investment readiness programme (Raise) for incorporated science teams. The organisation provides structured co-building sessions, 1:1 coaching, legal support via Orrick, investor introductions to a network of 700+ investors, and Demo Day pitching opportunities, all free of charge with no equity taken.

Product overview

Conception X is a not-for-profit venture-building platform that operates two core programmes for PhD researchers: Venture Scientist 100 (a 9-month fellowship) and Raise (a 10-week investment readiness track). The platform provides access to a curated ecosystem network of 1,500+ science founders, investors, and industry experts, an Industry Advisory Board featuring partners like NVIDIA, AstraZeneca, and IBM, and investment pathways through the Conception X Angel Syndicate and XTX Ventures partnership offering up to £300k. The company has helped launch 205 startups valued at over £1 billion, with 3 exits including acquisitions by EnergyHub and Odyssey Therapeutics, and team acquisitions by Anthropic.

Differentiator

Problem solved

Functional benefit

Products and services

  • Venture Scientist 100 Selective 9-month part-time venture-building fellowship for approximately 100 PhD founders annually, designed to run alongside PhD research. Includes 18 active co-building sessions, investment and expert coaching for top teams, 1:1 coaching, access to Europe's largest peer community of science founders, and integration with the PhD timeline. Free of charge with no equity taken.
  • Raise 10-week investment readiness programme for incorporated science teams preparing to raise pre-seed or seed funding. Includes personalized coaching, narrative and pitch development, fundraising strategy, direct access to a 700+ investor network, optional co-building sessions, legal support through partner Orrick, and the opportunity to pitch for up to £300k in equity investment from the Conception X Angel Syndicate and XTX Ventures at Demo Day.

Companies that use Conception X

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Conception X technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability12 records

Conception X partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • OrrickcoreImplementation/ SI/ Consulting PartnerTop-tier legal expertise partner providing support to programme participants on term sheets, fundraise structure, and IP guidance. Orrick has a proven track record advising innovative companies across Silicon Valley and Europe's tech ecosystem.
  • University College London (UCL)coreStrategic or Co-development PartnerKey academic partner with Professor David Barber serving on the Academic Advisory Board. Multiple founders from UCL have gone through the programme including Rahko (CX18) and TurinTech (CX19).
  • University of OxfordcoreStrategic or Co-development PartnerKey academic partner with Professor Ramana Nanda (Entrepreneurial Finance) on Academic Advisory Board. Notable alumni include Infinitopes (CX20, £27M raised) and GambitBio (CX23).
  • University of CambridgecoreStrategic or Co-development PartnerAcademic partner with Pam Garside (Partner at NewHealth & Fellow of Judge Business School) on Academic Advisory Board. Alumni include Nanomation (CX22) and ReactWise (CX24).
  • University of ManchestercoreStrategic or Co-development PartnerAcademic partner with Professors Aline Miller and Chris Taylor on Academic Advisory Board. Alumni include ARDHANN (CX25) and NeuWave (CX23).
  • Imperial College LondoncoreStrategic or Co-development PartnerAcademic partner with Professor Ramana Nanda on Academic Advisory Board. Alumni include Radiant Science (CX22/CX24).
  • NVIDIAminorGTM or Marketing PartnerIndustry Advisory Board member providing access to industry decision-makers and potential investment or partnership opportunities for portfolio companies.
  • AstraZenecaminorGTM or Marketing PartnerIndustry Advisory Board member with multiple representatives (Dr. Graham Clarke, Ryan Bate). Provides access to pharma/biotech expertise and potential commercial partnerships.
  • GlaxoSmithKlineminorGTM or Marketing PartnerIndustry Advisory Board member (Dr. Uche Agwo, Director of Academic Liaison) providing biotech/pharma industry perspective and potential partnerships.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Conception X competitors and assessment

Company assessment

Direct peers

  • Antler: Global venture builder/accelerator running cohort-based programmes to help early-stage founders build companies. While broader than deep tech, Antler competes for technical talent and operates similar fellowship-style programmes with investor demo days.
  • Deep Science Ventures: UK-based venture builder creating science-led startups across similar deeptech domains. Closest comparable to Conception X, also focuses on training scientists to become founders and operates cohort-based programmes with university and corporate partnerships.
  • Entrepreneur First: Global venture builder specifically targeting technical talent (often PhDs and researchers) to form companies from scratch. Operates similar cohort-based programmes with a focus on first-time technical founders, comparable to Conception X's VS100 model.
  • Creative Destruction Lab: Global deep tech accelerator providing objectives-based mentoring for science and technology founders. Operates similar cohort structures and supports ventures from lab to market, with strong university and industry partnerships comparable to Conception X.

Regional players

  • SETsquared Partnership: UK university business incubator partnership supporting deep tech and science founders from member universities. Provides similar incubation infrastructure, mentoring, and investor access for academic spinouts.
  • Pioneer Group: UK-focused deep tech accelerator and venture builder with programmes supporting science founders. Comparable mission of supporting deeptech ventures from universities with similar fellowship-style programming.

Others

  • Octopus Ventures (Deep Tech): UK-based venture firm with significant deep tech investment activity and ecosystem programmes supporting science founders. While primarily an investor rather than builder, operates similar ecosystem-building activities and participates in Conception X-style demo days.

Broad incumbents

  • Techstars: Established global accelerator network with multiple deep tech-focused programmes. Provides cohort-based mentoring, investor access, and demo days similar to Conception X's model, though operates as a for-profit entity taking equity.
  • SOSV: Multi-stage venture fund operating multiple vertical-specific accelerator programmes (HAX for hardware, IndieBio for biotech) similar to Conception X's deep tech specialization. Competes for science founder talent and provides comparable demo day investor access.
  • Y Combinator: Premier global accelerator with significant deep tech portfolio including AI and biotech companies. Operates a more capital-intensive model with equity participation, but competes for early-stage technical founder mindshare and provides comparable investor demo day access.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Conception X social profiles

Digital presence

Conception X financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Conception X leadership team

Management profile

Number of profiles

Profiles10 records

Conception X funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Conception X M&A and investment

M&A and investment

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conception X

What does Conception X do?

Conception X runs a 9-month part-time venture-building fellowship (Venture Scientist 100) for approximately 100 PhD researchers annually and a 10-week investment readiness programme (Raise) for incorporated science teams. The organisation provides structured co-building sessions, 1:1 coaching, legal support via Orrick, investor introductions to a network of 700+ investors, and Demo Day pitching opportunities, all free of charge with no equity taken.

Is Conception X a public or private company?

Conception X is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Conception X founded?

Conception X was founded in 2018. It employs 51 to 100 people.

Where is Conception X based?

Conception X is headquartered in London, United Kingdom, in the Europe region.

How does Conception X make money?

One revenue line is on record: non-revenue generating (Not-for-profit).

Who are Conception X's main competitors?

Direct peers on record are Antler, Deep Science Ventures, Entrepreneur First and Creative Destruction Lab. Regional players are SETsquared Partnership and Pioneer Group. Octopus Ventures (Deep Tech) is listed as an others. Broad incumbents are Techstars, SOSV and Y Combinator.

Does Conception X have an API?

No public API is recorded for Conception X.

What industry is Conception X in?

Conception X's product category is Venture Builder / Startup Accelerator. Its primary akta.pro industry code is FSANAAAH, Venture Studios / Company Builders, with a secondary code of FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 54169 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsQMatter Raises $1.2M in Pre-Seed FundingQMatter, a London-based quantum compression technology developer, raised $1.2M in pre-seed funding led by 55 North. The company will use the funds to develop and scale its platform, which reduces computational demands of molecular simulations. It is also generating physics-informed data libraries for machine learning.StartupmagQMatter secures £900k pre-seed for quantum compression to shrink drug discovery simulationsQMatter raised £900,000 in a pre-seed round led by 55 North to develop a quantum compression platform. The technology shrinks complex computational problems for drug discovery and materials research, aiming to make larger simulations tractable on current hardware. The funding will support further development and scaling of the platform.Tech Funding NewsUCL spinout QMatter raises $1.2M from 55 North to shrink quantum algorithms for drug discovery — TFNQMatter raised $1.2 million in pre-seed funding led by 55 North, with participation from XTX Ventures, Bellstate Oy, and the Conception X Angel Syndicate. The London-Boston startup's quantum compression platform accelerates molecular simulations for drug discovery, and it plans to seek a seed round in about a year.Tech.euQMatter secures $1.2M to tackle quantum scaling challengesQMatter raised $1.2 million in pre-seed funding led by 55 North. The quantum startup's compression technology reduces complex problems before processing, aiming to extend existing hardware capabilities. It will focus on life sciences and building data libraries for machine learning.LinkedInCollaboration drives innovation in graphene and 2D materialsConception X has opened applications for its 2026 programme, seeking 115 researchers from the UK and Europe to commercialize scientific discoveries. The initiative offers entrepreneurship training, mentorship, and potential early-stage investment of up to £250k or €350k through partners such as NVIDIA, Unilever, and AstraZeneca.WevolverThe future of wind energy is modularMyriad Wind Energy Systems, a start-up founded by PhD students, is developing multi-rotor wind turbines (MRWTs) to address logistical and economic bottlenecks in the traditional large-scale wind energy sector. The company aims to raise funding for a working demonstrator project within the next couple of years after winning the Conception X DemoDay Prize.CrowdFund InsiderDeloitte Becomes Exclusive Legal and Professional Services Partner of “Deep Tech” Phd Entrepreneurship Program Conception XDeloitte Legal became the exclusive legal and professional services partner of Conception X, a PhD entrepreneurship program for deep tech. The partnership, formalized after Conception X's participation in Deloitte Legal Ventures, will have students work with mentors to apply research to legal and business problems. Barclays Ventures, Conception X's founding partner, provides investment and backing.